T-cell therapy at the threshold

Despite impressive clinical activity in B-cell lymphoma and melanoma, questions remain about the immunobiology of adoptive T-cell therapies.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Author information

Correspondence to Carl June or Steven A Rosenberg or Michel Sadelain or Jeffrey S Weber.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

June, C., Rosenberg, S., Sadelain, M. et al. T-cell therapy at the threshold. Nat Biotechnol 30, 611–614 (2012) doi:10.1038/nbt.2305

Download citation

Further reading